Bone ongrowth of a cementless silver oxide-containing hydroxyapatite-coated antibacterial acetabular socket.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 30718042.
- Also identified by DOI 10.1016/j.jos.2018.12.031.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The silver oxide-containing hydroxyapatite-coated socket (KYOCERA, Osaka, Japan) is a cementless antibacterial implant that has both the osteoconductivity of the HA and the antibacterial activity of silver. The silver oxide-containing hydroxyapatite coating was shown to have good osteoconductivity and new bone formation in vitro and in vivo. However, the histological bone ongrowth of this implant has not been proven in a clinical study. We analyzed bone ongrowth using two silver oxide-containing hydroxyapatite-coated sockets that were removed in revision total hip arthroplasty for recurrent dislocation. A histomorphometric analysis was performed using a scanning electron microscope (SEM) connected to a CCD camera and an elemental analysis was performed by energy-dispersive elemental spectrometry (EDS). A white structure thought to be osseous tissue was attached to the retrieved socket surface macroscopically, and histological bone ongrowth of the silver oxide-containing hydroxyapatite coating of the socket was confirmed by SEM. In addition, the presence of silver in the silver oxide-containing hydroxyapatite coating was confirmed in an elemental analysis by EDS. Histologically, the silver oxide-containing hydroxyapatite-coated socket presented bone ongrowth in this clinical study.
Medical subject headings
- Arthroplasty, Replacement, Hip
- Coated Materials, Biocompatible
- Durapatite
- Hip Prosthesis
- Osseointegration
- Oxides
- Silver Compounds
Anatomy
- hip